
SpectralQC offers an end-to-end in-silico drug discovery platform for pharmaceutical R&D. The system uses quantum neural networks and AI to simulate molecular interactions. It is a B2B SaaS platform designed for pharmaceutical and biotech customers. The platform enables researchers to run scalable simulations and accelerate lead discovery. SpectralQC aims to scale drug discovery workflows across organizations.

SpectralQC offers an end-to-end in-silico drug discovery platform for pharmaceutical R&D. The system uses quantum neural networks and AI to simulate molecular interactions. It is a B2B SaaS platform designed for pharmaceutical and biotech customers. The platform enables researchers to run scalable simulations and accelerate lead discovery. SpectralQC aims to scale drug discovery workflows across organizations.